Showing results (151-160 of 640) with videos related to
Sort By:
Pageof 64
Vaccine|September 15, 2004
Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulinChia-Jung Hsieh, Tae Woo Kim, Chien-Fu Hung, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2015
Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital TractYun-Yan Sun, Shiwen Peng, Liping Han, et al.Cancer Immunology Research|January 25, 2018
Integration of Oncogenes via Sleeping Beauty as a Mouse Model of HPV16+ Oral Tumors and Immunologic ControlYi-Hsin Lin, Ming-Chieh Yang, Ssu-Hsueh Tseng, et al.Journal of Translational Medicine|April 22, 2024
Arginine-linked HPV-associated E7 displaying bacteria-derived outer membrane vesicles as a potent antigen-specific cancer vaccineSuyang Wang, Chao-Cheng Chen, Ming-Hung Hu, et al.Vaccine|May 17, 2005
Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesisWen-Fang Cheng, Chien-Fu Hung, Chi-An Chen, et al.The Laryngoscope|December 22, 2009
Characterization of human papillomavirus type 11-specific immune responses in a preclinical modelShiwen Peng, Simon R Best, Chien-Fu Hung, et al.Cell & Bioscience|February 27, 2016
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated diseaseShiwen Peng, Jin Qiu, Andrew Yang, et al.Plos One|January 7, 2015
Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancerShiwen Peng, Joshua W Wang, Balasubramanyam Karanam, et al.Cancer Research|April 17, 2010
Ectopic expression of X-linked lymphocyte-regulated protein pM1 renders tumor cells resistant to antitumor immunityTae Heung Kang, Kyung Hee Noh, Jin Hee Kim, et al.Journal of Molecular Medicine (Berlin, Germany)|May 30, 2013
Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccinationSung Yong Lee, Zhuomin Huang, Tae Heung Kang, et al.Pageof 64